SCHEMBL17375167

SCHEMBL17375167

CC(C)(C)[Si](C)(C)OC(CCN)Cc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.41
TAAR1 Q96RJ0 4/20 0.37
SLC6A2 P23975 3/20 0.37
CYP2A6 P11509 2/20 0.37
MAOA P21397 1/20 0.37
SLC6A4 P31645 1/20 0.37
SLC6A3 Q01959 1/20 0.37
SIGMAR1 Q99720 1/20 0.37
ADORA2A P29274 1/20 0.37
ADORA1 P30542 1/20 0.37
EPHX1 P07099 1/20 0.35
CYP2D6 P10635 2/20 0.35
HRH1 P35367 1/20 0.34
ANPEP P15144 1/20 0.33
LAP3 P28838 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
PRMT1 Q99873 1/20 0.33
HTR2A P28223 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20436626 0.85 TRPA1 (0.38) TAAR1SLC6A2CYP2A6MAOASLC6A4
SCHEMBL8072983 0.85 TAAR1 (0.33) ALDH1A1TAAR1SLC6A2CYP2A6MAOA
SCHEMBL24111210 0.78 LTA4H (0.46) CYP1A2
SCHEMBL388942 0.78 EPHX1 (0.48) TAAR1SLC6A2CYP2A6MAOASLC6A4
SCHEMBL13594158 0.77 SIGMAR1 (0.44) TAAR1SLC6A2CYP2A6MAOASLC6A4
SCHEMBL24111209 0.75 CYP1A2 (0.37) CYP1A2
SCHEMBL12569402 0.75 ALDH1A1 (0.53) ALDH1A1TAAR1SLC6A2CYP2A6MAOA
SCHEMBL17754425 0.75 CYP2D6 (0.45) TAAR1SLC6A2CYP2A6MAOASLC6A4
SCHEMBL11233017 0.75 ALDH1A1 (0.47) ALDH1A1TAAR1SLC6A2CYP2A6MAOA
SCHEMBL10771862 0.74 CTSS (0.43) ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3160966-A1 MNK INHIBITORS AND METHODS RELATED THERETO Effector Therapeutics Inc. (US) 2017-05-03 EP disclosed
WO-2015200481-A1 MNK INHIBITORS AND METHODS RELATED THERETO EFFECTOR THERAPEUTICS, INC. (US) 2015-12-30 WO disclosed